Guggenheim Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $588K | Sell |
|
|||||
|
2025
Q2 | $529K | Buy |
|
|||||
|
2025
Q1 | $450K | Buy |
|
|||||
|
2024
Q4 | $601K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $44K | Sell |
|
|||||
|
2017
Q1 | $77K | Sell |
|
|||||
|
2016
Q4 | $84K | Sell |
|
|||||
|
2016
Q3 | $104K | Sell |
|
|||||
|
2016
Q2 | $127K | Sell |
|
|||||
|
2016
Q1 | $123K | Sell |
|
|||||
|
2015
Q4 | $4.82M | Sell |
|
|||||
|
2015
Q3 | $4.37M | Buy |
|
|||||
|
2015
Q2 | $8.96M | Buy |
|
|||||
|
2015
Q1 | $7.44M | Sell |
|
|||||
|
2014
Q4 | $5.11M | Buy |
|
|||||
|
2014
Q3 | $3.29M | Buy |
|
|||||
|
2014
Q2 | $3.52M | Sell |
|
|||||
|
2014
Q1 | $4.21M | Buy |
|
|||||
|
2013
Q4 | $4.74M | Buy |
|
|||||
|
2013
Q3 | $5.67M | Sell |
|
|||||
|
2013
Q2 | $3.01M | Buy |
|